Programmed cell death: a promising management for Alzheimer's disease - PubMed
5 hours ago
- #Biomarkers
- #Programmed Cell Death
- #Alzheimer's Disease
- Alzheimer's disease (AD) is a major health issue for older adults with increasing mortality, but delaying or halting progression has been challenging.
- Programmed cell death (PCD) is a genetically regulated form of cell death crucial for development and homeostasis.
- Various PCD processes like autophagy, ferroptosis, and pyroptosis are linked to AD onset, progression, and prognosis.
- This review covers recent advances in using PCD for biomarker identification and therapeutic innovation in AD diagnosis and management.
- It also explores challenges and opportunities in employing PCD as novel strategies, aiming to shift focus from treatment to prevention.